Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moine, P.
Right arrow Articles by Gajdos, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moine, P.
Right arrow Articles by Gajdos, P.

Chest, Vol 105, 1487-1495, Copyright © 1994 by American College of Chest Physicians

ARTICLES

Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors. French Study Group for Community-Acquired Pneumonia in the Intensive Care Unit

P Moine, JB Vercken, S Chevret, C Chastang and P Gajdos
Service de Reanimation Medicale, Hopital Raymond Poincare, Garches, France.

A prospective study of 132 patients with severe community-acquired pneumonia (CAP) treated in the ICU was carried out to determine the causative agents, the value of the clinical, biological, and radiologic features in predicting the etiology, and to define prognostic factors. The study group included 98 men and 34 women (mean age: 58 +/- 18 years). The most frequent underlying condition was COPD (51 patients, 39 percent). On admission, 35 patients were in shock, 71 were mentally confused, and 81 (61 percent) required mechanical ventilation during their hospitalization. The clinical, laboratory, and radiologic parameters were of little value for predicting the etiology in patients with severe CAP. An etiologic diagnosis was made in 95 (72 percent) patients. The most frequent pathogens were Streptococcus pneumoniae (43 cases [45 percent]), Gram-negative bacilli (14 cases [15 percent]), and Haemophilus influenzae (14 cases [15 percent]) Mortality was 24 percent. It was significantly associated with a age more than 60 years, septic shock, impairment of alertness, mechanical ventilation requirement, bacteremic pneumonia, and S pneumoniae or Enterobacteriaceae as the causes of the pneumonia. Recommendations for antibiotic chemotherapy in patients with severe CAP admitted to the ICU are included.


This article has been cited by other articles:


Home page
 ChestHome page
M. I. Restrepo, E. M. Mortensen, J. A. Velez, C. Frei, and A. Anzueto
A Comparative Study of Community-Acquired Pneumonia Patients Admitted to the Ward and the ICU
Chest, March 1, 2008; 133(3): 610 - 617.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
E. Azoulay-Dupuis, J. Mohler, J. P. Bedos, C. Barau, and B. Fantin
Efficacy of Cethromycin, a New Ketolide, against Streptococcus pneumoniae Susceptible or Resistant to Erythromycin in a Murine Pneumonia Model.
Antimicrob. Agents Chemother., September 1, 2006; 50(9): 3033 - 3038.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
W.-S. Leung, C.-M. Chu, K.-Y. Tsang, F.-H. Lo, K.-F. Lo, and P.-L. Ho
Fulminant Community-Acquired Acinetobacter baumannii Pneumonia as a Distinct Clinical Syndrome
Chest, January 1, 2006; 129(1): 102 - 109.
[Abstract] [Full Text] [PDF]

Home page
 Emerg. Med. J.Home page
P Malhotra and S K Jindal
Does noninvasive ventilation work in ARDS? A case report and review of the current literature
Emerg. Med. J., October 1, 2005; 22(10): 745 - 746.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
N. A. Smyrnios, O. P. Schaefer, R. M. Collins, and J. M. Madison
Applicability of Prediction Rules in Patients With Community-Acquired Pneumonia Requiring Intensive Care: A Pilot Study
J Intensive Care Med, July 1, 2005; 20(4): 226 - 232.
[Abstract] [PDF]

Home page
 ChestHome page
O. Leroy, P. Saux, J.-P. Bedos, E. Caulin, and for the Levofloxacin Study Group
Comparison of Levofloxacin and Cefotaxime Combined With Ofloxacin for ICU Patients With Community-Acquired Pneumonia Who Do Not Require Vasopressors
Chest, July 1, 2005; 128(1): 172 - 183.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
E. Azoulay-Dupuis, J. P. Bedos, J. Mohler, P. Moine, C. Cherbuliez, G. Peytavin, B. Fantin, and T. Kohler
Activity of Gemifloxacin against Quinolone-Resistant Streptococcus pneumoniae Strains In Vitro and in a Mouse Pneumonia Model
Antimicrob. Agents Chemother., March 1, 2005; 49(3): 1046 - 1054.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
F. Paganin, F. Lilienthal, A. Bourdin, N. Lugagne, F. Tixier, R. Genin, and J-L. Yvin
Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor
Eur. Respir. J., November 1, 2004; 24(5): 779 - 785.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
E. Azoulay-Dupuis, J. P. Bedos, J. Mohler, A. Schmitt-Hoffmann, M. Schleimer, and S. Shapiro
Efficacy of BAL5788, a Prodrug of Cephalosporin BAL9141, in a Mouse Model of Acute Pneumococcal Pneumonia
Antimicrob. Agents Chemother., April 1, 2004; 48(4): 1105 - 1111.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
E. Azoulay-Dupuis, J. P. Bedos, J. Mohler, G. Peytavin, R. Isturiz, P. Moine, V. Rieux, C. Cherbuliez, J. C. Pechere, B. Fantin, et al.
Activities of Garenoxacin against Quinolone-Resistant Streptococcus pneumoniae Strains In Vitro and in a Mouse Pneumonia Model
Antimicrob. Agents Chemother., March 1, 2004; 48(3): 765 - 773.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
O. Leroy, T. d'Escrivan, H. Georges, and S. Alfandari
Impact of Positive Microbiological Diagnosis on Management and Prognosis of Severe Community-Acquired Pneumonia
Chest, September 1, 2003; 124(3): 1179 - 1180.
[Full Text]

Home page
 ChestHome page
C. M. Luna
Blood Cultures in Community-Acquired Pneumonia: Are We Ready To Quit?
Chest, April 1, 2003; 123(4): 977 - 978.
[Full Text] [PDF]

Home page
 ChestHome page
S. G. Campbell, T. J. Marrie, R. Anstey, G. Dickinson, and S. Ackroyd-Stolarz
The Contribution of Blood Cultures to the Clinical Management of Adult Patients Admitted to the Hospital With Community-Acquired Pneumonia: A Prospective Observational Study
Chest, April 1, 2003; 123(4): 1142 - 1150.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
J. P. Metlay and M. J. Fine
Testing Strategies in the Initial Management of Patients with Community-Acquired Pneumonia
Ann Intern Med, January 21, 2003; 138(2): 109 - 118.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
F. Arancibia, T. T. Bauer, S. Ewig, J. Mensa, J. Gonzalez, M. S. Niederman, and A. Torres
Community-Acquired Pneumonia Due to Gram-Negative Bacteria and Pseudomonas aeruginosa: Incidence, Risk, and Prognosis
Arch Intern Med, September 9, 2002; 162(16): 1849 - 1858.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. Menendez, D. Ferrando, J. M. Valles, and J. Vallterra
Influence of Deviation From Guidelines on the Outcome of Community-Acquired Pneumonia*
Chest, August 1, 2002; 122(2): 612 - 617.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
E. Prats, J. Dorca, M. Pujol, L. Garcia, B. Barreiro, R. Verdaguer, F. Gudiol, and F. Manresa
Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia
Eur. Respir. J., May 1, 2002; 19(5): 944 - 951.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
S V Baudouin
The pulmonary physician in critical care 3: Critical care management of community acquired pneumonia
Thorax, March 1, 2002; 57(3): 267 - 271.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J Dakin and M Griffiths
The pulmonary physician in critical care 1: Pulmonary investigations for acute respiratory failure
Thorax, January 1, 2002; 57(1): 79 - 85.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
H. G. Birnbaum, M. Morley, P. E. Greenberg, M. Cifaldi, and G. L. Colice
Economic Burden of Pneumonia in an Employed Population
Arch Intern Med, December 10, 2001; 161(22): 2725 - 2731.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults
Thorax, December 1, 2001; 56(90004): iv1 - 64.
[Full Text] [PDF]

Home page
 ChestHome page
M.-Z. Chen, P.-R. Hsueh, L.-N. Lee, C.-J. Yu, P.-C. Yang, and K.-T. Luh
Severe Community-Acquired Pneumonia due to Acinetobacter baumannii
Chest, October 1, 2001; 120(4): 1072 - 1077.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
S V Baudouin
Ventilator induced lung injury and infection in the critically ill
Thorax, September 1, 2001; 56(90002): ii50 - 57.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. S. Niederman, L. A. Mandell, A. Anzueto, J. B. Bass, W. A. Broughton, G. D. Campbell, N. Dean, T. File, M. J. Fine, P. A. Gross, et al.
Guidelines for the Management of Adults with Community-acquired Pneumonia . Diagnosis, Assessment of Severity, Antimicrobial Therapy, and Prevention
Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1730 - 1754.
[Full Text] [PDF]

Home page
 NEJMHome page
P. E. Marik
Aspiration Pneumonitis and Aspiration Pneumonia
N. Engl. J. Med., March 1, 2001; 344(9): 665 - 671.
[Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
E. Azoulay-Dupuis, V. Rieux, M. Muffat-Joly, J. P. Bédos, E. Vallée, C. Rivier, R. Isturiz, C. Carbon, and P. Moine
Relationship between Capsular Type, Penicillin Susceptibility, and Virulence of Human Streptococcus pneumoniae Isolates in Mice
Antimicrob. Agents Chemother., June 1, 2000; 44(6): 1575 - 1577.
[Abstract] [Full Text]

Home page
 J Antimicrob ChemotherHome page
F. A. Al-Eidan, J. C. McElnay, M. G. Scott, M. P. Kearney, J. Corrigan, and J. B. McConnell
Use of a treatment protocol in the management of community-acquired lower respiratory tract infection
J. Antimicrob. Chemother., March 1, 2000; 45(3): 387 - 394.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
F. E. Pascual, M. A. Matthay, P. Bacchetti, and R. M. Wachter
Assessment of Prognosis in Patients With Community-Acquired Pneumonia Who Require Mechanical Ventilation
Chest, February 1, 2000; 117(2): 503 - 512.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
P. Reittner, N. L. Muller, L. Heyneman, T. Johkoh, J. S. Park, K. S. Lee, O. Honda, and N. Tomiyama
Mycoplasma pneumoniae Pneumonia: Radiographic and High-Resolution CT Features in 28 Patients
Am. J. Roentgenol., January 1, 2000; 174(1): 37 - 41.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. CONFALONIERI, A. POTENA, G. CARBONE, R. D. PORTA, E. A. TOLLEY, and G. UMBERTO MEDURI
Acute Respiratory Failure in Patients with Severe Community-acquired Pneumonia . A Prospective Randomized Evaluation of Noninvasive Ventilation
Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1585 - 1591.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. RUIZ, S. EWIG, A. TORRES, F. ARANCIBIA, F. MARCO, J. MENSA, M. SANCHEZ, and J. A. MARTINEZ
Severe Community-acquired Pneumonia . Risk Factors and Follow-up Epidemiology
Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 923 - 929.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. RUIZ, S. EWIG, M. A. MARCOS, J. A. MARTINEZ, F. ARANCIBIA, J. MENSA, and A. TORRES
Etiology of Community-Acquired Pneumonia: . Impact of Age, Comorbidity, and Severity
Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 397 - 405.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. SANYAL, P. R. SMITH, A. C. SAHA, S. GUPTA, L. BERKOWITZ, and P. HOMEL
Initial Microbiologic Studies Did Not Affect Outcome in Adults Hospitalized with Community-Acquired Pneumonia
Am. J. Respir. Crit. Care Med., July 1, 1999; 160(1): 346 - 348.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. EWIG, M. RUIZ, J. MENSA, M. A. MARCOS, J. A. MARTINEZ, F. ARANCIBIA, M. S. NIEDERMAN, and A. TORRES
Severe Community-acquired Pneumonia . Assessment of Severity Criteria
Am. J. Respir. Crit. Care Med., October 1, 1998; 158(4): 1102 - 1108.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J.-P. Bédos, E. Azoulay-Dupuis, P. Moine, M. Muffat-Joly, B. Veber, J.-J. Pocidalo, and E. Vallée
Pharmacodynamic Activities of Ciprofloxacin and Sparfloxacin in a Murine Pneumococcal Pneumonia Model: Relevance for Drug Efficacy
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 29 - 35.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. EL-EBIARY, X. SARMIENTO, A. TORRES, S. NOGUÉ, E. MESALLES, M. BODÍ, and J. ALMIRALL
Prognostic Factors of Severe Legionella Pneumonia Requiring Admission to ICU
Am. J. Respir. Crit. Care Med., November 1, 1997; 156(5): 1467 - 1472.
[Abstract] [Full Text]

Home page
 NEJMHome page
L. A. Mandell, M. S. Niederman, W. G. Boersma, Y. Holloway, E. A. Halm, J. P. Metlay, D. E. Singer, M. J. Fine, and J. G. Bartlett
Community-Acquired Pneumonia
N. Engl. J. Med., March 28, 1996; 334(13): 861 - 863.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American College of Chest Physicians.